Article
Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management
18 May 2018
Abstract excerpt
Disease overview Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder with overlapping features of myelodysplastic syndromes and myeloproliferative neoplasms, with an inherent risk for leukemic transformation (∼15%‐20% over 3‐5 years). Diagnosis Diagnosis is based on the presence of sustained (>3 months) peripheral blood monocytosis (≥1 × 109/L; monocytes ≥10%), along with bone...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
